Home > Cashflow Statement > BIOCON

BIOCON
Cashflow Statement

BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax₹1,887 Cr₹1,525 Cr₹897 Cr₹983 Cr₹1,068 Cr
Adjustment ₹1,711 Cr₹2,356 Cr₹1,685 Cr₹1,245 Cr₹710 Cr
Changes In working Capital ₹923 Cr₹-635 Cr₹-501 Cr₹-790 Cr₹-424 Cr
Cash Flow after changes in Working Capital ₹4,521 Cr₹3,246 Cr₹2,081 Cr₹1,439 Cr₹1,354 Cr
Cash Flow from Operating Activities ₹4,061 Cr₹2,954 Cr₹1,853 Cr₹1,177 Cr₹1,160 Cr
Cash Flow from Investing Activities ₹-234 Cr₹-1,005 Cr₹-14,282 Cr₹-1,699 Cr₹-3,625 Cr
Cash Flow from Financing Activities ₹-1,854 Cr₹-2,333 Cr₹13,049 Cr₹242 Cr₹2,564 Cr
Net Cash Inflow / Outflow ₹1,973 Cr₹-383 Cr₹619 Cr₹-280 Cr₹99 Cr
Opening Cash & Cash Equivalents ₹920 Cr₹1,300 Cr₹654 Cr₹897 Cr₹825 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger ---₹34 Cr₹-34 Cr
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations ₹31 Cr₹2.90 Cr₹22 Cr₹3.30 Cr₹7.10 Cr
Closing Cash & Cash Equivalent ₹2,924 Cr₹920 Cr₹1,295 Cr₹654 Cr₹897 Cr

Compare Cashflow Statement of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹47,944.8 Cr -0.2% -9% 2.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹384,002.0 Cr -2.1% -5.8% -6.7% Stock Analytics
DIVIS LABORATORIES ₹164,334.0 Cr 3.1% -6.5% 28.7% Stock Analytics
CIPLA ₹127,613.0 Cr 2.2% 3.2% 1.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,923.0 Cr -1.7% NA 9.6% Stock Analytics
DR REDDYS LABORATORIES ₹105,437.0 Cr 1.4% -1.1% -7.6% Stock Analytics


BIOCON Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

-0.2%

-9%

2.4%

SENSEX

-1.1%

-1.7%

-0.3%


You may also like the below Video Courses